Demographics of patients in public dataset (GSE10846)
| . | Subgroup A (n = 262) . | Subgroup B (n = 152) . | P . |
|---|---|---|---|
| Age, y | |||
| ≤60 | 119 (45) | 69 (45) | 1 |
| >60 | 143 (55) | 83 (55) | |
| Sex | |||
| Female | 108 (41) | 64 (42) | .834 |
| Male | 143 (55) | 81 (53) | |
| NA | 11 (4) | 7 (5) | |
| IPI | |||
| ≤2 | 204 (78) | 124 (82) | .383 |
| >2 | 58 (22) | 28 (18) | |
| Risk | |||
| High risk | 58 (22) | 28 (18) | .517 |
| Low risk | 161 (62) | 95 (63) | |
| NA | 43 (16) | 29 (19) | |
| No. of extranodal sites | |||
| ≤1 | 166 (63) | 100 (66) | 1 |
| >1 | 19 (7) | 11 (7) | |
| NA | 77 (30) | 41 (27) | |
| Stage | |||
| >2 | 262 (100) | 152 (100) | NA |
| ECOG PS | |||
| ≤2 | 226 (86) | 130 (85) | .345 |
| >2 | 24 (9) | 9 (6) | |
| NA | 12 (5) | 13 (9) | |
| COO: ABC vs GCB | |||
| ABC | 125 (48) | 42 (28) | .011 |
| GCB | 113 (43) | 70 (46) | |
| Unclassified | 24 (9) | 40 (26) | |
| COO: GCB vs non-GCB | |||
| GCB | 113 (43) | 70 (46) | .608 |
| non-GCB | 149 (57) | 82 (54) | |
| LDH | |||
| ≤1 | 102 (39) | 71 (47) | .045 |
| >1 | 124 (47) | 54 (35) | |
| NA | 36 (14) | 27 (18) |
| . | Subgroup A (n = 262) . | Subgroup B (n = 152) . | P . |
|---|---|---|---|
| Age, y | |||
| ≤60 | 119 (45) | 69 (45) | 1 |
| >60 | 143 (55) | 83 (55) | |
| Sex | |||
| Female | 108 (41) | 64 (42) | .834 |
| Male | 143 (55) | 81 (53) | |
| NA | 11 (4) | 7 (5) | |
| IPI | |||
| ≤2 | 204 (78) | 124 (82) | .383 |
| >2 | 58 (22) | 28 (18) | |
| Risk | |||
| High risk | 58 (22) | 28 (18) | .517 |
| Low risk | 161 (62) | 95 (63) | |
| NA | 43 (16) | 29 (19) | |
| No. of extranodal sites | |||
| ≤1 | 166 (63) | 100 (66) | 1 |
| >1 | 19 (7) | 11 (7) | |
| NA | 77 (30) | 41 (27) | |
| Stage | |||
| >2 | 262 (100) | 152 (100) | NA |
| ECOG PS | |||
| ≤2 | 226 (86) | 130 (85) | .345 |
| >2 | 24 (9) | 9 (6) | |
| NA | 12 (5) | 13 (9) | |
| COO: ABC vs GCB | |||
| ABC | 125 (48) | 42 (28) | .011 |
| GCB | 113 (43) | 70 (46) | |
| Unclassified | 24 (9) | 40 (26) | |
| COO: GCB vs non-GCB | |||
| GCB | 113 (43) | 70 (46) | .608 |
| non-GCB | 149 (57) | 82 (54) | |
| LDH | |||
| ≤1 | 102 (39) | 71 (47) | .045 |
| >1 | 124 (47) | 54 (35) | |
| NA | 36 (14) | 27 (18) |
All data are n (%).
ECOG PS, Eastern Cooperative Oncology Group performance status; IPI, International Prognostic Index; LDH, lactic acid dehydrogenase; NA, not available.